Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|January 30, 2018
The Expanding Therapeutic Perspective of CCR5 BlockadeLuca Vangelista, Sandro Vento
Biologics : Targets & Therapy|September 24, 2009
Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcomaFrancesca Cainelli, Alfredo Vallone
Tropical Medicine & International Health : TM & IH|May 12, 2011
Stroke: a realistic approach to a growing problem in sub-Saharan Africa is urgently neededKehinde O Kolapo, Sandro Vento
Drugs of Today (Barcelona, Spain : 1998)|October 28, 2009
Micafungin - the newest echinocandinZelalem Temesgen, Jason Barreto, Sandro Vento
Biomedicines|February 26, 2025
Advances in HIV Treatment: Long-Acting Antiretrovirals and the Path Toward a CureMassimiliano Lanzafame, Giovanni Mori, Sandro Vento
The Pan African Medical Journal|October 14, 2014
Thrombotic Thrombocytopenic Purpura-Haemolytic Uremic Syndrome and pregnancyJulius Chacha Mwita, Sandro Vento, Tadele Benti
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2008
EtravirineBettina M Knoll, Sandro Vento, Zelalem Temesgen
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 12, 2013
Comparative chromatography-mass spectrometry studies on the antiretroviral drug nevirapine-analytical performance characteristics in human plasma determinationKwenga Sichilongo, Mompati Chinyama, Amos Massele, et al.
Expert Opinion on Pharmacotherapy|March 12, 2004
Initial antiretroviral therapy in chronically-infected HIV-positive adultsZelalem Temesgen, Francesca Cainelli, David Warnke, et al.
Journal of the International AIDS Society|November 15, 2014
Efficacy of a reduced dose of DARUNAVIR/RTV in a cohort of antiretroviral-naïve and experienced HIV-infected patients: a medium-term follow-upMassimiliano Lanzafame, Emanuela Lattuada, Fabio Rigo, et al.
Pageof 7